Visualitza Vall d'Hebron Barcelona Hospital Campus - VH per autor "D'Arcy, Sophie"
Ara mostrant els elements 1-1 d 1
-
The Next-Generation Oral Selective Estrogen Receptor Degrader Camizestrant (AZD9833) Suppresses ER+ Breast Cancer Growth and Overcomes Endocrine and CDK4/6 Inhibitor Resistance
Lawson, Mandy; Cureton, Natalie; Ros, Susana; Cheraghchi-Bashi, Azadeh; Urosevic, Jelena; D'Arcy, Sophie; Serra, Violeta (American Association for Cancer Research, 2023-12-01)